<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/WebSite>
<http://www.genengnews.com/Registration.aspx?ReturnURL=%2Fgen-news-highlights%2Fallergan-licenses-molecular-partners-phase-ii-eye-disease-protein-therapeutic-for-45m%2F81245102%2F>